Skip to content
V

V. Meghashree

Publications (3)

Evaluation of Salivary Interleukin-1 Beta in Covid Recovered Patients

Harini Palani, Palati Sinduja, R. Priyadharshini & V. Meghashree · Journal of Pharmaceutical Research International · 2021

Introduction: The COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The epidemic started in Wuhan in mid-December 2019 and quickly spread across the world as a pandemic. Saliva is emerging as a promising alternative to nasopharyngeal/oropharyngea...

Open access Research Article 10.9734/jpri/2021/v33i57A33999

Evaluation of C-reactive Protein Levels in the Saliva of Covid Recovered Patients

Soorya Ganesh, Palati Sinduja, . Priyadharshini & V. Meghashree · Journal of Pharmaceutical Research International · 2021

Introduction: The acute phase reactant synthesized by the liver. CRP is an annular (ring- shaped) metameric protein set up in plasma, whose circulating immersion rise in response to inflammation. The idea of the study is to estimate the C-reactive protein situations in the saliva...

Open access Research Article 10.9734/jpri/2021/v33i57A34005

Comparison of Efficacy of the Pap and H & E in Identifying the Various Changes in Liver Samples of High Fat Diet Induced Rat - In vitro Study

E. Dhivya Sri, R. Priyadharshini, Palati Sinduja & V. Meghashree · Journal of Pharmaceutical Research International · 2021

Introduction: High fat induced (HFI) liver is associated with a high calorie intake and many other diet-induced complications, such as metabolic syndrome and cardiovascular disease. HFI is the most common chronic liver disease that develops due to high fat intake. A wide range of...

Open access Research Article 10.9734/jpri/2021/v33i54A33757